RNS Number : 1235L
Ondo InsurTech PLC
01 September 2023
 

                                                                                                                                                1 September 2023

 

Ondo InsurTech Plc

("Ondo" or "the Company")

 

Total Voting Rights and Shares in issue update

Ondo InsurTech Plc ("Ondo"), the London-listed leader in claims prevention technology for home insurers, is pleased to provide an update on its Share in Issue and Total Voting rights in accordance with the Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1,

 

Since our announcement on 15 August 2023, a further 562,500 shares have been issued pursuant to warrant exercises and these shares were admitted to trading under the Company's blocklisting arrangement.

 

This brings the total shares issued for the calendar month of August from the exercise of warrants and options to 2,057,549.

 

The Company's issued share capital as at 31 August 2023 now comprises 80,427,159 ordinary shares of 5p each.  The Company holds no shares in treasury.

 

Each ordinary share carries the right to one vote in relation to all circumstances at general meetings of the Company.  The total number of voting rights in the Company is therefore 80,427,159.

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

 

Enquiries

 

For further information, please visit www.ondoplc.com  or contact the following:

Ondo InsurTech Plc

Craig Foster, CEO

+44 (0) 800 783 9866

SI Capital Ltd

(Company Broker)

Nick Emerson

Jon Levinson

+44 (0) 1483 413500

+44 (0) 20 3143 0600

Cassiopeia Services Ltd

(PR & Investor Relations)

Stefania Barbaglio

+44 (0) 7949 690338

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRKZGGLRMKGFZG